ArticleRSC advances2026
Adsorption-synergized reduction of Cr(vi) using Gypsum@PANI composite: unraveling mechanism and advanced statistical physics prediction.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cr(vi) is categorized as a top-priority hazardous contaminant. The subsequent adsorption/reduction of Cr(vi) into Cr(iii) has emerged as a powerful process for detoxifying Cr(vi)-laden waters. Herein, a newly designed Gypsum@Polyaniline (Gypsum@PANI) composite was applied for the detoxification of Cr(vi) ions in aqueous solutions. The as-developed Gypsum@PANI composite exhibited a mesoporous texture abundantly decorated with amine/imine groups. Based on the response surface modeling, the Cr(vi) adsorption effectiveness reached 93.86% under optimized conditions (pH 2, adsorbent dosage of 0.35 g L
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.